Related Experiment Video
Updated: Aug 9, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and
Sourabh Soni1,2, Prince Anand1,2, Mohit Kumar Swarnkar3
1Pharmacology and Toxicology Laboratory, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur 176061, India.
Abstract:
Transcriptome analysis of head and neck squamous cell carcinoma (HNSCC) has been pivotal to comprehending the convoluted biology of HNSCC tumors. MAPKAPK2 or MK2 is a critical modulator of the mRNA turnover of crucial genes involved in HNSCC progression. However, MK2-centric transcriptome profiles of tumors are not well known. This study delves into HNSCC progression with MK2 at the nexus to delineate the biological relevance and intricate crosstalk of MK2 in the tumor milieu. We performed next-generation sequencing-based transcriptome profiling of HNSCC cells and xenograft tumors to ascertain mRNA expression profiles in MK2-wild type and MK2-knockdown conditions. The findings were validated using gene expression assays, immunohistochemistry, and transcript turnover studies. Here, we identified a pool of crucial MK2-regulated candidate genes by annotation and differential gene expression analyses. Regulatory network and pathway enrichment revealed their significance and involvement in the HNSCC pathogenesis. Additionally, 3'-UTR-based filtering recognized important MK2-regulated downstream target genes and validated them by nCounter gene expression assays. Finally, immunohistochemistry and transcript stability studies revealed the putative role of MK2 in regulating the transcript turnover of IGFBP2, MUC4, and PRKAR2B in HNSCC. Conclusively, MK2-regulated candidate genes were identified in this study, and their plausible involvement in HNSCC pathogenesis was elucidated. These genes possess investigative values as targets for diagnosis and therapeutic interventions for HNSCC.
Insights
This study reveals key genes regulated by MAPKAPK2 (MK2) in head and neck squamous cell carcinoma (HNSCC). These MK2-controlled genes offer potential new targets for HNSCC diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Head and neck squamous cell carcinoma (HNSCC) biology is complex.
- MAPKAPK2 (MK2) influences mRNA turnover in HNSCC progression.
- MK2's specific role in HNSCC tumor transcriptomes is not fully understood.
Purpose of the Study:
- To investigate the biological relevance and molecular interactions of MK2 in HNSCC.
- To identify MK2-regulated genes and their role in HNSCC pathogenesis.
- To explore MK2's function in regulating mRNA turnover within the tumor microenvironment.
Main Methods:
- Next-generation sequencing for transcriptome profiling of HNSCC cells and xenografts.
- Differential gene expression analysis and regulatory network construction.
- Validation using gene expression assays, immunohistochemistry, and transcript stability studies.
Main Results:
- A set of crucial MK2-regulated candidate genes involved in HNSCC pathogenesis were identified.
- 3'-UTR analysis pinpointed downstream MK2 target genes, including IGFBP2, MUC4, and PRKAR2B.
- MK2 was shown to potentially regulate the transcript turnover of specific genes in HNSCC.
Conclusions:
- This study identified novel MK2-regulated genes in HNSCC.
- The findings elucidate the plausible involvement of these genes in HNSCC development.
- These identified genes represent potential targets for HNSCC diagnostics and therapeutics.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

